India's First Integrated Digital Accelerator

Juno Therapeutics Sectors, Funding and Contact Details

Seattle, Washington, United States

Juno Therapeutics

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.

Status

Acquired

Sectors

• Biotechnology • Clinical Trials • Health Care • Medical • Therapeutics

Employees

Founders

Isabelle Rivière, Michael Jensen, Michel Sadelain, Phil Greenberg, Renier Brentjens, Stan Riddell

Last Funding

8/5/2014

Listed/Private

Delisted

Funding Stage

Size

Founded

January 1, 2013

Investors

ARCH Venture Partners, Venrock, Bezos Expeditions, Alaska Permanent Fund

Acquisitions

5

Ticker

JUNO

Study your competition to stay ahead